Loading insider details...
Beta
Latest Form 4 (Sep 25, 2026): Grant/Award of 39,674 STOK shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 39,674 | n/a |
| Jun 13, 2026 | Vor Biopharma Inc. (VOR) | Grant/Award | 56,345 | n/a |
| Jun 8, 2026 | Climb Bio, Inc. (CLYM) | Grant/Award | 40,000 | n/a |
| Apr 21, 2026 | Solid Biosciences Inc. (SLDB) | Grant/Award | 169,401 | n/a |
| Feb 19, 2026 | Solid Biosciences Inc. (SLDB) | Exercise/Conversion | 30,031 | n/a |
| Feb 6, 2026 | Solid Biosciences Inc. (SLDB) | Sale | 48,913 | $315.1K |
| Feb 3, 2026 | Solid Biosciences Inc. (SLDB) | Exercise/Conversion | 169,401 | n/a |
| Dec 4, 2025 | Solid Biosciences Inc. (SLDB) | Exercise/Conversion | 28,612 | n/a |
| Aug 18, 2025 | Solid Biosciences Inc. (SLDB) | Grant/Award | 337,500 | n/a |
| Jul 18, 2025 | Vor Biopharma Inc. (VOR) | Grant/Award | 60,000 | n/a |